Retatrutide includes GLP-1 activity, but it is not only a GLP-1 drug
Management options include dose reduction of the GLP-1 receptor agonist, switching to an alternative agent in the class, or temporarily discontinuing therapy to assess whether heart rate normalizes
We help you improve your cardiovascular health, manage stress and increase your energy and vitality
Dose, cap, refrigerate, done
Yes, Wegovy (semaglutide) is available on the NHS, however access is currently limited and subject to specific eligibility criteria
Safety, Side Effects, and Clinical Expectations Common side effects of semaglutide include nausea, constipation, and mild headachetypically mild and self-limiting during the first 23 weeks of treatment